Fig. 2.
Cumulative risk of recurrent venous thromboembolism related to management. VKA, vitamin K antagonist; LMWH, low molecular weight heparins. Based on a competing risk analysis.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.